Lex Witness, a magazine focussed on legal and corporate affairs recently hosted Pharma Legal & Compliance Summit (PLCS 2012) in Mumbai. An initiative undertaken for pharma companies, biopharma firms and medical device manufacturers, the summit provided an ideal platform to all business experts and stakeholders to come together and discuss issues relating to current regulatory developments, ethics and compliance issues, contract management, licensing agreements as well as develop a proactive legal strategy for patent litigations.
Speaking on the occasion, PBA Srinivasan, Editor-in-Chief, Lex Witness said, “The bio-pharmaceutical industry of India is in its emerging stage and hence, now is the time to revise the legal and compliance strategies concerned so as to ensure sustenance and future growth. Marketing practices by pharma companies of pushing their products to foreign countries is against the medical ethics and MCI rules. The need of the hour is to bring into force a new code of conduct so as to knock down the doctor-pharmaceutical nexus running in the country.”
The day long discussion focussed on fraud and corruption management, legal and regulatory compliance of ethics for pharma and bio-pharma companies in India, legal risk management strategies for new product launches, current regulatory developments and implications of changes to regulatory framework, trends in patent opposition and litigation, recent developments in pre-grant and post-grant opposition, settlement strategies, key elements of a compliance programme, recent changes in clinical trials documentation requirements in india, current legal issues in domestic and cross border site contracts and contracts, claims and counter claims and licensing agreements.
The convention saw participation of various law firms, copyright societies, regulatory and patent filing consultants sharing their views and proficiency on the grave concerns affecting their territories. The proficient speakers’ panel included Ajay Thomas, Registrar, LCIA India; Debolina Partap, Associate Vice President and Head Legal, Wockhardt Group India; Girish Gokhale, President Legal & Group General Counsel, JSW Group; KP Pradeep, Sr Manager Compliance, MSD; Marshall Mendonza, Vice President – Legal & Company Secretary, Glenmark Pharmaceuticals; Milind Antani, Head, Pharma & Life Sciences Practice Group; Nishith Desai Associates, Nasser Kabir, Vice President Legal, Strides Arcolab; Priti Suri, Founder Partner, PSA; Rajeev Mukundan, General Counsel and Chief Compliance Officer, Mylan Laboratories; Suhas Tuljapurkar, Managing Partner, Legasis Partners & Director, Legasis Services and Vivek Mittal, Head Legal, Lupin Pharma.
Summing up the learning’s of the day Shyam Grover, Group Editor and CEO, Lex Witness said “Indian pharma industry is escalating up the value chain and its future development demand that all the rules and regulations which guide, monitor and control the conducts of the contributors of the country’s healthcare system and also examine the means to bring them at par with international standards. I am delighted that we took one small step towards progress by bringing together so many professionals of pharma sphere under one roof who made us see where we stand as of now and where we have to reach.”
The PLCS 2012 pioneering initiative was conceived by Lex Witness as part of a knowledge series and was sponsored by Legasis as Knowledge Partner, Nishith Desai Associates as Legal Partner, TMT Law Practices and PSA as Silver Partners, Laser GRC Solutions as Technology Partner. NMIMS Institute of Intellectual Property Studies supported the summit as Academic Partner and Society of Indian Law Firms (SILF) as Supporting Partner. The media partners to the summit include Express Pharma, India Law Journal, Lawyers Club India, Think Legal and National Bar Association of India.
EP News Bureau
- Advertisement -
